KRAS and cancer: While the acquisition and accumulation of driver mutations is recognized to lead to the onset and progression of cancer, some critical driver genes, such as EGFR, TP53, or KRAS, are known to dramatically accelerate cancer progression by, for instance, elevating cell proliferation or avoiding apoptosis [2, 25, 26].